KOR

e-Article

Ripretinib Versus Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumor after Treatment with Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 1 December 2022, 40(34):3918-3928)
Subject
Language
English
ISSN
15277755
0732183X